BeOne Medicines (ONC) Preferred Stock Liabilities (2015)
BeOne Medicines (ONC) posted quarterly Preferred Stock Liabilities of $176.1 million for Q4 2015.
Powered by 
Analysis
BeOne Medicines (ONC) Preferred Stock Liabilities (2015) Analysis & Trends
BeOne Medicines (ONC) has reported Preferred Stock Liabilities for 1 consecutive years, with $176.1 million the latest figure, recorded in Q4 2015.
- In Q4 2015, Preferred Stock Liabilities changed N/A year-over-year to $176.1 million; the TTM figure through Dec 2015 stood at $176.1 million (changed N/A YoY), while the FY2015 annual figure was $176.1 million, changed N/A from the prior year.
- Preferred Stock Liabilities held at $176.1 million in Q4 2015 per ONC's latest filing.
- Across five years, Preferred Stock Liabilities topped out at $176.1 million in Q4 2015 and bottomed at $176.1 million in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.57 Bn | 21.04 Bn | 1.57 Bn | - |